References
Anwer MS, Engelkind LR, Nolan K, Sullivan D, Zimniak P, et al. Hepatotoxic bile acids increase cyostolic Ca++ activity of isolated rat hepatocytes. Hepatology 8: 887–891, 1988
Baldessarini RJ. Neuropharmacology of 5-adenosyl-L-methionine. American Journal of Medicine 83(Suppl. 5A): 95–103, 1987
Batlle AM del C. Lead intoxication and acute porphyria: development and positive experience in their therapy. In Nordmann Y (Ed.) Porphyrins and porphyrias, pp. 189–200, Libbey Eurotext, London, 1986
Batlle AM del C, Paredes SR, Fukuda H, Kozicki PA, Rossetti MV. S-adenosyl-L-methionine, a mechanism for its action on lead mobilization and disposal in lead poisoning. Biochemical Archives 2: 293–303, 1986
Batlle AM del C, Stella AM, DeKaminsky AR, Kaminsky C, Mariano HG. Two cases of infantile porphyria cutanea tarda: successful treatment with oral S-adenosyl-L-methionine and low-dose oral chloroquine. British Journal of Dermatology 116: 407–415, 1987
Batlle A, Stella AM, Melito V, Gomez HL, Pietropaolo N, et al. Erythropoietic protoporphyria and S-adenosyl-L-methionine. International Journal of Biochemistry, in press
Berger R, Nowak H. A new medical approach to the treatment of osteoarthritis. American Journal of Medicine 83(Suppl. 5A): 84–88, 1987
Bonfirraro G, Chieffi O, Quinti R, Tedesco R, Le Grazie C, et al. S-adenosyl-L-mcthionine (SAMe)-induced amelioration of intrahepatic cholestasis of pregnancy. Results of an open study. Drug Investigation 2: 125–128, 1990
Cantoni L, Budillon G, Cuomo R, Rodinò S, Le Grazie C, et al. Protective effect of S-adenosyl-L-methionine in hepatic uroporphyria. Evaluation in an experimental model. Scandinavian Journal of Gastroenterology 25: 1039–1040, 1990
Combettes L, Berthon B, Doucet E, Erlinger S, Claret M. Characteristics of bile acid-mediated Ca2+ release from permeabilized liver cells and liver microsomes. Journal of Biological Chemistry 264: 157–167, 1989
Crabb DW. Biological markers for increased risk of alcoholism and for quantitation of alcohol consumption. Journal of Clinical Investigation 85: 311–315, 1990
Crivelli O, Lavarini C, Chiaberge E, et al. Microsomal autoantibodies in chronic infections with the HBsAg associated delta (δ) agent. Clinical and Experimental Immunology 54: 232–238, 1983
Cuomo R, Rodinò S, Cantoni L, Rizzoli R, Simoni P, et al. Bile and biliary lipid secretion in rats with hexachlorobenzene-induced porphyria. Effect of S-adenosyl-L-methionine administration. Journal of Hepatology, in press
Everson GT, Ahnen D, Harper PC, Krawitt EL. Benign recurrent intrahepatic cholestasis: treatment with S-adenosylmethionine. Gastroenterology 96: 1354–1357, 1989
Farrell GC, Duddy SK, Kass GEN, Liopis J, Gahm A, et al. Release of Ca2+ from the endoplasmic reticulum is not the mechanism for bile acid-induced cholestasis and hepatotoxicity in the intact rat liver. Journal of Clinical Investigation 85(4): 1255–1259, 1990
Fazio C, Andreoli V, Agnoli A, Cassacchia M, Cerbo R. Effecti terapeutici e meccanismo d’azione della S-adenosil-L-metionina (SAMe) nella sindromi depressive. Minerva Medica 64: 1515–1529, 1973
Frezza M, Di Padova C, Pozzato G, Terpin M, Baraona E, et al. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. New England Journal of Medicine 322: 95–99, 1990
Frezza M, Pozzato G, Chiesa L, Stramentinoli G, Di Padova C. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. Hepatology 4: 274–278, 1984
Frezza M, Surrenti C, Manzillo G, Fiaccadori F, Bortolini M, et al. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study. Gastroenterology 99: 211–215, 1990
Fricker G, Landmann L, Meier PJ. Ethinylestradiol (EE) induced structural and functional alterations of rat liver plasma membranes and their, reversal by S-adenosylmethionine (SAMe) in vitro. Hepatology 8: 1224, 1988
Fricker G, Landmann L, Meier PJ. Extra-hepatic obstructive cholestasis reverses the bile salt secretory polarity of rat hepatocytes. Journal of Clinical Investigation 84: 876–885, 1989
Goedde HW, Agarwal DP. Polymorphism of aldehyde dehydrogenase and alcohol sensitivity. Enzyme 37: 29–44, 1987
Hagenbuch B, Lübbert H, Stieger B, Meier PJ. Expression of the hepatocyte Na+/bile acid cotransporter in Xenopus laevis oocytes. Journal of Biological Chemistry 265: 5357–5360, 1990
Hong WJ, Petell JK, Swank D, Sanford J, Hixson DC, et al. Expression of dipeptidyl peptidase IV in rat tissues is mainly regulated at the mRNA levels. Experimental Cell Research 182: 256–266, 1989
Jackson PA, Morgan DB. The relationship between membrane cholesterol and phospholipid and sodium efflux in erythrocytes from healthy subjects and patients with chronic cholestasis. Clinical Science 62: 104–107, 1982
James DFW. Ursodeoxycholic acid treatment for chronic cholestatic liver disease. Journal of Hepatology 11: 5–8, 1990
Kamimoto Y, Gatmaitan Z, Hsu J, Arias IM. The function of Gp 170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. Journal of Biological Chemistry 264: 11693–11698, 1989
Koga Y. Anticholestatic and cytoprotective properties of ursodeoxycholic acid — studies in vivo and in vitro. Acta Hepatologica Japonica 28: 1597–1604, 1987
Lafuenti G, Plotti G, Nicolanti G, Caruso A, Tibollo FG, et al. Valutazione delle modificazioni di parametri clinici e biochimici in gravide con colestasi in terapia con S-adenosyl-l-methionine per os. Giornale Italiano Ostetricia e Ginecologia 5: 357–361, 1988
Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 335: 258–259, 1990
Lieber CS, Casini A, De Carli LM, Kim C-I, Lowe N, et al. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology 11: 165–172, 1990
Lin SH, Guidotti G. Cloning and expression of a cDNA coding for a rat liver plasma membrane ecto-ATPase. The primary structure of the ecto-ATPase is similar to that in the human biliary glycoprotein I. Journal of Biological Chemistry 264: 14408–14414, 1989
McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, et al. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false positive result? Lancet 1: 754–757, 1990
Muriel P, Mourelle M. Prevention and reversion of erythrocyte membrane alterations in cirrhosis by S-adenosylmethionine. Hepatology 10: 742, 1989
Rafique S, Guardascione M, Burroughs AK, Owen JS. S-Adenosylmethionine (SAMe) reduces cholesterol deposition in erythrocyte membranes of cirrhotic patients. Journal of Hepatology 11(2): S51, 1990
eichen J, Berr F, Le M, Warren GH. Characterization of calcium deprivation-induced cholestasis in the perfused rat liver. American Journal of Physiology 249: G48–G57, 1985
Schachter D. Fluidity and function of hepatocyte plasma membranes. Hepatology 4: 140–151, 1984
Scharschmidt BF, Lake JR. Hepatocellular bile acid transport and ursodeoxycholic acid hypercholeresis. Digestive Diseases and Sciences 34 (Suppl.): 5S–15S, 1989
Schölmerich J, Baumgartner U, Miyoi K, Gerok W. Taurourso-deoxycholate prevents taurolithocholate-induced cholestasis and toxicity in rat liver. Journal of Hepatology 10: 280–283, 1990
Schreiber AJ, Simon FR. Estrogen-induced cholestasis: clues to pathogenesis and treatment. Hepatology 3: 607–613, 1983
Scott PD, Knoop M, McMahon RT, Braganza JM, Hutchinson IV. Usefulness of sulphadenosylmethionine (SAMe) in a transplant model of acute haemorrhagic pancreatitis (AHP). Digestion 46: 176–177, 1990
Sellinger M, Boyer JL. Physiology of bile secretion and cholestatis. Progress in Liver Diseases 9: 237–259, 1990
Stammler L, Reichen J, Oehler R, Bianchi L, Landmann L. Decreased hepatocellular volume and intact morphology of tight junctions in calcium deprivation-induced cholestasis. Journal of Hepatology 10: 318–326, 1990
Stramentinoli G. Pharmacologic aspects of S-adenosyl methionine. American Journal of Medicine 83(Suppl. 5A): 35–42, 1987
Stramentinoli G, Gualano M, Galli-Kienle M. Intestinal absorption of S-adenosyl-L-methionine. Journal of Pharmacology and Experimental Therapeutics 209: 323–326, 1979
Stricker & Spoelstra (Eds) Drug-induced hepatic injury, Elsevier, Amsterdam, 1985
Thomas CE, Reed DJ. Current status of calcium in hepatocellular injury. Hepatology 10: 375–384, 1989
Tolbert LC. MAT kinetics in affective disorders and schizophrenia. An account. Alabama Journal of Medical Science 25: 291–296, 1988
Traver J, Varela I, Mato JM. Effect of exogenous S-adenosyl-L-methionine on phosphatidylcholine synthesis by isolated rat hepatocytes. Biochemical Pharmacology 33: 1562–1564, 1984
Vendemiale G, Altomare E, Trizio T, Le Grazie C, Di Padova C, et al. Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scandinavian Journal of Gastroenterology 24(4): 407–415, 1989
von Dippe P, Levy D. Expression of the bile acid transport protein during liver development and in hepatoma cells. Journal of Biological Chemistry 265: 5942–5945, 1990
Yoshida T, Bonkovsky H, Ansari A, Danner D. Antibodies against mitochondrial dehydrogenase complexes in primary biliary cirrhosis. Gastroenterology 99: 187–194, 1990
Yoshihara H, Sato N, Kamada T, Abe H. Low Km ALDH isozymes and alcoholic liver injury. Pharmacology, Biochemistry and Behaviour 18(Suppl. 1): 425–428, 1983
Zimmermann HJ, Lewis JH. Drug induced cholestasis. Medical Toxicology 2: 112–160, 1987
Rights and permissions
About this article
Cite this article
Round-Table Discussion. Drugs 40 (Suppl 3), 129–138 (1990). https://doi.org/10.2165/00003495-199000403-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199000403-00013